pI: 11.1975 |
Length (AA): 96 |
MW (Da): 10799 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
11 | 82 | 1jj2 (Y) | 11 | 82 | 35.00 | 0 | 0.62 | 1.0453 | 0.98 |
11 | 83 | 1ffk (W) | 11 | 80 | 40.00 | 0.0000000000055 | 0.63 | 1.01052 | 1.6 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte, merozoite, sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite, Oocyst, Ring, Sporozoite, Female Gametocyte, Male Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_127166)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G10950 | putative 60S ribosomal protein L37a-1 |
Arabidopsis thaliana | AT3G60245 | zinc-binding ribosomal protein family protein |
Babesia bovis | BBOV_IV002760 | ribosomal protein L37a, putative |
Brugia malayi | Bm1_52705 | 60S ribosomal protein L37a |
Caenorhabditis elegans | CELE_Y48B6A.2 | Protein RPL-43 |
Cryptosporidium parvum | cgd3_2250 | 60S ribosomal protein L37A |
Dictyostelium discoideum | DDB_G0281093 | S60 ribosomal protein L37A |
Drosophila melanogaster | Dmel_CG5827 | Ribosomal protein L37A |
Echinococcus granulosus | EgrG_000419400 | ribosomal protein smL37a |
Entamoeba histolytica | EHI_008650 | 60S ribosomal protein L37a, putative |
Entamoeba histolytica | EHI_148230 | 60S ribosomal protein L37a, putative |
Echinococcus multilocularis | EmuJ_000419400 | ribosomal protein smL37a |
Giardia lamblia | GL50803_5517 | Ribosomal protein L37a |
Homo sapiens | 6168 | ribosomal protein L37a |
Leishmania braziliensis | LbrM.35.2130 | 60S ribosomal protein L37a |
Leishmania braziliensis | LbrM.33.0880 | 60S ribosomal protein L37a |
Leishmania donovani | LdBPK_362020.1 | 60S ribosomal protein L37a |
Leishmania donovani | LdBPK_212190.1 | 60S ribosomal protein L37a, putative |
Leishmania infantum | LinJ.21.2190 | 60S ribosomal protein L37a, putative |
Leishmania infantum | LinJ.36.2020 | 60S ribosomal protein L37a |
Leishmania major | LmjF.21.1820 | 60S ribosomal protein L37a, putative |
Leishmania major | LmjF.36.1925 | 60S ribosomal protein L37a |
Leishmania mexicana | LmxM.36.1925 | 60S ribosomal protein L37a |
Leishmania mexicana | LmxM.21.1820 | 60S ribosomal protein L37a, putative |
Loa Loa (eye worm) | LOAG_00043 | 60S ribosomal protein L37a |
Mus musculus | ENSMUSG00000046330 | ribosomal protein L37a |
Neospora caninum | NCLIV_064540 | Ribosomal protein L37a, related |
Oryza sativa | 4339573 | Os05g0557000 |
Oryza sativa | 4325282 | Os01g0679700 |
Plasmodium berghei | PBANKA_0307000 | 60S ribosomal protein L37ae, putative |
Plasmodium falciparum | PF3D7_0210100 | 60S ribosomal protein L37ae, putative |
Plasmodium knowlesi | PKNH_0411100 | ribosomal L37ae protein, putative |
Plasmodium vivax | PVX_003955 | 60S ribosomal protein L37a, putative |
Plasmodium yoelii | PY06446 | Ribosomal L37ae protein family, putative |
Saccharomyces cerevisiae | YPR043W | ribosomal 60S subunit protein L43A |
Saccharomyces cerevisiae | YJR094W-A | ribosomal 60S subunit protein L43B |
Schistosoma japonicum | Sjp_0075890 | ko:K02921 large subunit ribosomal protein L37Ae, putative |
Schistosoma mansoni | Smp_105320 | ribosomal protein smL37a |
Schmidtea mediterranea | mk4.011282.00 | 60S ribosomal protein L37a |
Schmidtea mediterranea | mk4.009377.01 | 60S ribosomal protein L37a |
Trypanosoma brucei gambiense | Tbg972.10.7770 | 60S ribosomal proteins L37, putative |
Trypanosoma brucei | Tb927.10.6370 | 60S ribosomal proteins L37, putative |
Trypanosoma brucei | Tb927.10.220 | 60S ribosomal protein L37a, putative |
Trypanosoma cruzi | TcCLB.511145.46 | 60S ribosomal protein L37a, putative |
Trypanosoma cruzi | TcCLB.507641.233 | ribosomal protein L37, putative |
Trypanosoma cruzi | TcCLB.504069.56 | 60S ribosomal protein L37a, putative |
Toxoplasma gondii | TGME49_325400 | ribosomal L37ae family protein |
Toxoplasma gondii | TGME49_300190 | ribosomal protein RPL37A |
Theileria parva | TP03_0371 | 60S ribosomal protein L37a, putative |
Trichomonas vaginalis | TVAG_099020 | eukaryotic translation initiation factor 4g, putative |
Trichomonas vaginalis | TVAG_370820 | 60S ribosomal protein L37a, putative |
Trichomonas vaginalis | TVAG_083700 | 60S ribosomal protein L37a, putative |
Trichomonas vaginalis | TVAG_197730 | 50S ribosomal protein l37ae, putative |
Trichomonas vaginalis | TVAG_283240 | 50S ribosomal protein l37ae, putative |
Trichomonas vaginalis | TVAG_124410 | 50S ribosomal protein l37ae, putative |
Trichomonas vaginalis | TVAG_212620 | 60S ribosomal protein L37a, putative |
Trichomonas vaginalis | TVAG_083720 | eukaryotic translation initiation factor 4g, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.6370 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.6370 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.6370 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.6370 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.10.220 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.220 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.220 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.220 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y48B6A.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y48B6A.2 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_Y48B6A.2 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_300190 | Toxoplasma gondii | Probably essential | sidik |
TGME49_325400 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.